Ballentine Partners, LLC Takeda Pharmaceutical CO LTD Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q4 2024
A detailed history of Ballentine Partners, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Ballentine Partners, LLC holds 38,662 shares of TAK stock, worth $499,513. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,662
Previous 31,094
24.34%
Holding current value
$499,513
Previous $441,000
15.87%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding TAK
# of Institutions
336Shares Held
73.8MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$170 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$69.2 Million0.01% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$65.8 Million1.21% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$59.9 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$58.9 Million0.01% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $40.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...